Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

AKTS

Aktis Oncology, Inc.

CIK 0002035832 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$28.42
↓ 0.27 (-0.94%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Excluded: Fundamentals, Options (no data)

Key stats

Market Cap
$1.52B
P/E Ratio
Not covered
EPS
Not covered
Dividend Yield
Not covered
52W Position
70%
Beta
1.62

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.00
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

124 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 70%
$14.72$34.19

Latest Financials

–
Revenue
–
Net Income
–
Total Assets
–
Free Cash Flow
–

Recent news